S91 - Syngeneic Model
Rincon Bio performs S91 syngeneic models to test efficacy of immunotherapies. Please see below for additional information or to request a quote.
Clone M-3, a melanin-producing cell line was adapted to cell culture by Y. Yasumura, A.H. Tashjian and G. Sato from a Cloudman S91 melanoma in a (C X DBA) F1 male mouse obtained from the Jackson Memorial Laboratory, Bar Harbor, Maine.
Used as a syngeneic model. Implanted tumor cells create a model in which to test the efficacy of novel immunotherapies
Grows in C57BL / Balb/C mice
Rincon Bio Growth Curve
S91 in Matrigel vs No Matrigel
Cell Line: S91
Mouse Strain: Balb/C
Positive Control: None
Matrigel: Half yes, half no
From implant to stratification: N/A
Cells Implanted per Animal: 1 million
WHY WORK WITH
DOMESTIC QUALITY at COMPETITIVE PRICES
When you work with Rincon Bio, rest assured that all cancer efficacy studies will be performed in the USA, at competitive prices
SPEED TO INITIATION
Most efficacy studies can be initiated within two business days.
We love our clients. We are easy to work with. And we develop a personal interest in our clients and their studies.